These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 10873099
21. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents. Sudbeck EA, Liu XP, Narla RK, Mahajan S, Ghosh S, Mao C, Uckun FM. Clin Cancer Res; 1999 Jun; 5(6):1569-82. PubMed ID: 10389946 [Abstract] [Full Text] [Related]
22. Fas signaling and blockade of Bcr-Abl kinase induce apoptotic Hrk protein via DREAM inhibition in human leukemia cells. Sanz C, Horita M, Fernandez-Luna JL. Haematologica; 2002 Sep; 87(9):903-7. PubMed ID: 12217801 [Abstract] [Full Text] [Related]
23. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571. Koyama N, Koschmieder S, Tyagi S, Portero-Robles I, Chromic J, Myloch S, Nürnberger H, Rossmanith T, Hofmann WK, Hoelzer D, Ottmann OG. Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2025-31. PubMed ID: 16609011 [Abstract] [Full Text] [Related]
24. The p54 cleaved form of the tyrosine kinase Lyn generated by caspases during BCR-induced cell death in B lymphoma acts as a negative regulator of apoptosis. Luciano F, Herrant M, Jacquel A, Ricci JE, Auberger P. FASEB J; 2003 Apr 01; 17(6):711-3. PubMed ID: 12586738 [Abstract] [Full Text] [Related]
25. Resistance to TRAIL-induced apoptosis caused by constitutional phosphorylation of Akt and PTEN in acute lymphoblastic leukemia cells. Dida F, Li Y, Iwao A, Deguchi T, Azuma E, Komada Y. Exp Hematol; 2008 Oct 01; 36(10):1343-53. PubMed ID: 18599181 [Abstract] [Full Text] [Related]
26. Induction of apoptosis in Eμ-myc lymphoma cells in vitro and in vivo through calpain inhibition. Li H, Nepal RM, Martin A, Berger SA. Exp Hematol; 2012 Jul 01; 40(7):548-563.e2. PubMed ID: 22366408 [Abstract] [Full Text] [Related]
27. CD40L induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase independent and dependent pathways. Voorzanger-Rousselot N, Alberti L, Blay JY. BMC Cancer; 2006 Mar 18; 6():75. PubMed ID: 16545138 [Abstract] [Full Text] [Related]
34. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells. Liu JH, Liu CC, Yen CC, Gau JP, Wang WS, Tzeng CH. Int J Cancer; 2009 Jul 01; 125(1):71-7. PubMed ID: 19291793 [Abstract] [Full Text] [Related]
36. Inhibition of imatinib-mediated apoptosis by the caspase-cleaved form of the tyrosine kinase Lyn in chronic myelogenous leukemia cells. Gamas P, Marchetti S, Puissant A, Grosso S, Jacquel A, Colosetti P, Pasquet JM, Mahon FX, Cassuto JP, Auberger P. Leukemia; 2009 Aug 01; 23(8):1500-6. PubMed ID: 19340007 [Abstract] [Full Text] [Related]
37. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148). Beran M, Cao X, Estrov Z, Jeha S, Jin G, O'Brien S, Talpaz M, Arlinghaus RB, Lydon NB, Kantarjian H. Clin Cancer Res; 1998 Jul 01; 4(7):1661-72. PubMed ID: 9676840 [Abstract] [Full Text] [Related]